Abstract
Recent data on prognostic and predictive significance of breast cancer-associated molecular markers are presented and their clinical value in making individual prognosis and choosing adequate therapy is discussed. Markers of tumor proliferation, steroid hormone receptors, factors of epidermal cell growth, plasminogen activators and inhibitors, factors influencing angiogenesis and apoptosis and genome characteristics are considered. It is concluded that only Ki-67, ER, PR and Her-2/neu may be recommended for clinical use.
Cite
CITATION STYLE
Bozhok, A. A., Semiglazov, V. F., Semiglazov, V. V., Arzumanov, A. S., & Kletsel, A. E. (2005). Prognostic and predictive factors in breast cancer. Voprosy Onkologii, 51(4), 434–443.
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
